Overview
| Uniprot ID | Q9H7Z6 |
| Protein Name | Histone acetyltransferase KAT8 |
| Gene Name | KAT8 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position |
Flanking peptide |
| 121 |
TVKDAVQKNSEKYLS |
| 145 |
ITRNQKRKHDEINHV |
Function
Histone acetyltransferase that catalyzes histone H4 acetylation at 'Lys-5'- and 'Lys-8' (H4K5ac and H4K8ac) or 'Lys-16' (H4K16ac), depending on the context (PubMed:12397079, PubMed:16227571, PubMed:16543150, PubMed:20018852, PubMed:21217699, PubMed:22020126, PubMed:22547026, PubMed:31794431, PubMed:33837287). Catalytic component of the MSL histone acetyltransferase complex, a multiprotein complex that mediates the majority of histone H4 acetylation at 'Lys-16' (H4K16ac), an epigenetic mark that prevents chromatin compaction (PubMed:12397079, PubMed:16227571, PubMed:16543150, PubMed:21217699, PubMed:22020126, PubMed:22547026, PubMed:33657400, PubMed:33837287). H4K16ac constitutes the only acetylation mark intergenerationally transmitted and regulates key biological processes, such as oogenesis, embryonic stem cell pluripotency, hematopoiesis or glucose metabolism (By similarity). The MSL complex is required for chromosome stability and genome integrity by maintaining homeostatic levels of H4K16ac (PubMed:33837287). The MSL complex is also involved in gene dosage by promoting up-regulation of genes expressed by the X chromosome (By similarity). X up-regulation is required to compensate for autosomal biallelic expression (By similarity). The MSL complex also participates in gene dosage compensation by promoting expression of Tsix non-coding RNA (By similarity). As part of the NSL histone acetyltransferase complex, catalyzes histone H4 acetylation at 'Lys-5'- and 'Lys-8' (H4K5ac and H4K8ac) at transcription start sites and promotes transcription initiation (PubMed:20018852, PubMed:22547026, PubMed:33657400). The NSL complex also acts as a regulator of gene expression in mitochondria: KAT8 associates with mitochondrial DNA and controls expression of respiratory genes in an acetyltransferase-dependent mechanism (PubMed:27768893). Also functions as an acetyltransferase for non-histone targets, such as ALKBH5, COX17, IRF3, KDM1A/LSD1, LMNA, PAX7 or TP53/p53 (PubMed:17189187, PubMed:19854137, PubMed:37369679). Acts as an inhibitor of antiviral immunity by acetylating IRF3, preventing IRF3 recruitment to promoters (By similarity). Acts as a regulator of asymmetric division in muscle stem cells by mediating acetylation of PAX7 (By similarity). As part of the NSL complex, acetylates TP53/p53 at 'Lys-120' (PubMed:17189187, PubMed:19854137). Acts as a regulator of epithelial-to-mesenchymal transition as part of the NSL complex by mediating acetylation of KDM1A/LSD1 (PubMed:27292636). The NSL complex is required for nuclear architecture maintenance by mediating acetylation of LMNA (By similarity). Promotes mitochondrial integrity by catalyzing acetylation of COX17 (By similarity). In addition to protein acetyltransferase activity, able to mediate protein propionylation (PubMed:29321206)
Protein Sequence
10
MAAQGAAAAV
20
AAGTSGVAGE
30
GEPGPGENAA
40
AEGTAPSPGR
50
VSPPTPARGE
60
PEVTVEIGET
70
YLCRRPDSTW
80
HSAEVIQSRV
90
NDQEGREEFY
100
VHYVGFNRRL
110
DEWVDKNRLA
120
LTKTVKDAVQ
130
KNSEKYLSEL
140
AEQPERKITR
150
NQKRKHDEIN
160
HVQKTYAEMD
170
PTTAALEKEH
180
EAITKVKYVD
190
KIHIGNYEID
200
AWYFSPFPED
210
YGKQPKLWLC
220
EYCLKYMKYE
230
KSYRFHLGQC
240
QWRQPPGKEI
250
YRKSNISVYE
260
VDGKDHKIYC
270
QNLCLLAKLF
280
LDHKTLYFDV
290
EPFVFYILTE
300
VDRQGAHIVG
310
YFSKEKESPD
320
GNNVACILTL
330
PPYQRRGYGK
340
FLIAFSYELS
350
KLESTVGSPE
360
KPLSDLGKLS
370
YRSYWSWVLL
380
EILRDFRGTL
390
SIKDLSQMTS
400
ITQNDIISTL
410
QSLNMVKYWK
420
GQHVICVTPK
430
LVEEHLKSAQ
440
YKKPPITVDS
450
VCLKWAPPKH
KQVKLSKK
Gene Ontology
| Classification |
GO ID |
Description |
| Cellular Component |
GO:0005694 |
chromosome |
| Cellular Component |
GO:0000123 |
histone acetyltransferase complex |
| Cellular Component |
GO:0000776 |
kinetochore |
| Cellular Component |
GO:0005739 |
mitochondrion |
| Cellular Component |
GO:0071339 |
MLL1 complex |
| Cellular Component |
GO:0072487 |
MSL complex |
| Cellular Component |
GO:0044545 |
NSL complex |
| Cellular Component |
GO:0035267 |
NuA4 histone acetyltransferase complex |
| Cellular Component |
GO:0016363 |
nuclear matrix |
| Cellular Component |
GO:0005654 |
nucleoplasm |
| Cellular Component |
GO:0005634 |
nucleus |
| Molecular Function |
GO:0019899 |
enzyme binding |
| Molecular Function |
GO:0010485 |
histone H4 acetyltransferase activity |
| Molecular Function |
GO:0046972 |
histone H4K16 acetyltransferase activity |
| Molecular Function |
GO:0043995 |
histone H4K5 acetyltransferase activity |
| Molecular Function |
GO:0043996 |
histone H4K8 acetyltransferase activity |
| Molecular Function |
GO:1990841 |
promoter-specific chromatin binding |
| Molecular Function |
GO:0061920 |
protein propionyltransferase activity |
| Molecular Function |
GO:0061733 |
protein-lysine-acetyltransferase activity |
| Molecular Function |
GO:0061629 |
RNA polymerase II-specific DNA-binding transcription factor binding |
| Molecular Function |
GO:0003713 |
transcription coactivator activity |
| Molecular Function |
GO:0008270 |
zinc ion binding |
| Biological Process |
GO:0009048 |
dosage compensation by inactivation of X chromosome |
| Biological Process |
GO:0030099 |
myeloid cell differentiation |
| Biological Process |
GO:0045892 |
negative regulation of DNA-templated transcription |
| Biological Process |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition |
| Biological Process |
GO:0032480 |
negative regulation of type I interferon production |
| Biological Process |
GO:0022008 |
neurogenesis |
| Biological Process |
GO:0048477 |
oogenesis |
| Biological Process |
GO:0045893 |
positive regulation of DNA-templated transcription |
| Biological Process |
GO:1902726 |
positive regulation of skeletal muscle satellite cell differentiation |
| Biological Process |
GO:0060261 |
positive regulation of transcription initiation by RNA polymerase II |
| Biological Process |
GO:0035166 |
post-embryonic hemopoiesis |
| Biological Process |
GO:0010506 |
regulation of autophagy |
| Biological Process |
GO:1903108 |
regulation of mitochondrial transcription |
| Biological Process |
GO:0050684 |
regulation of mRNA processing |
| Biological Process |
GO:0045815 |
transcription initiation-coupled chromatin remodeling |
Reference
[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.